Study Stopped
Covid-19
Machine Learning Neurofeedback for PTSD
NEUROFPTSD
A Virtual World/Neurofeedback Real Time Functional MRI Approach to PTSD Treatment
1 other identifier
interventional
14
1 country
1
Brief Summary
A commonly used therapy for post-traumatic stress disorder (PTSD) that often (but not always) gives good results is "exposure therapy": When the patient (for example, Veterans who have attacks of anxiety when a noise startles them) talks about the trauma that precipitated the PTSD, she or he slowly becomes less sensitive to PTSD. This works only on some patients. The investigators propose to expose PTSD patients to a number of "training" sessions in which they will be in a virtual world (similar to a video game) driving a car through a place resembling Iraq. This will happen inside an MRI machine, and the investigators will obtain brain images while the patient is exploring the "virtual Iraq" environment. The investigators will project on the screen a bar that will let the patient know, in real time, which is the state of her or his brain, from CALM to STRESS. The job of the patient will be to try to come up with personal strategies (breathe slowly, think calming thoughts) to try to bring the bar to CALM. The investigators believe that after a number of sessions, the patient will be able to create personalized mental strategies to bring their brain to CALM state, even in real life. This could become a much stronger way of performing "exposure therapy". Finally, the investigators will use a wearable device (similar to a wristwatch) to be able to study physical activity and sleep patters in PTSD patients through the training, in the hope that the investigators may find a way to objectively study when a patient is doing better.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedStudy Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 24, 2020
CompletedResults Posted
Study results publicly available
June 28, 2024
CompletedJune 28, 2024
March 1, 2024
1.8 years
March 16, 2018
February 16, 2022
March 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
CAPS-5 PTSD Criteria
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) is a 30-item structured interview that can be used to determine: current (past month) diagnosis of PTSD, lifetime diagnosis of PTSD, PTSD symptoms over the past week. Scores range from 0 - 80, with higher scores indicating increased PTSD symptom severity. The full interview takes 45-60 minutes to administer. In addition to PTSD symptoms, questions target symptom onset and duration, subjective distress, impact of symptoms on social and occupational functioning, overall response validity, overall PTSD severity, and specifications for the dissociative subtype (depersonalization and derealization). The CAPS-5 produces reliable and valid scores with standard administration. It should be administered by qualified interviewers with formal training in structured clinical interviewing and differential diagnosis, a thorough understanding of the conceptual basis of PTSD, and detailed knowledge of the measure's features and conventions.
6 weeks
Secondary Outcomes (3)
Wearable Device Data: Heart Rate
Change from baseline at 6 weeks
Wearable Device Data: Sleep Patterns
Change from baseline at 6 weeks
Wearable Device Data: Total Sleep
Change from baseline at 6 weeks
Study Arms (1)
PTSD patients
EXPERIMENTAL12 PTSD patients will be recruited to undergo neurofeedback training .
Interventions
Patients will be inside an MRI machine. They will be trained using real time feedback from brain imaging to learn personal strategies to bring their brain to the CALM state.
Eligibility Criteria
You may qualify if:
- Meet CAPS5 PTSD criteria
- OEF/OIF/OND \& PGW Veterans
- Seeking treatment for PTSD
You may not qualify if:
- DSM-5 criteria for drug or alcohol abuse or dependence in past 30 days
- History of moderate to severe traumatic brain injury
- Presence of contraindications to MRI
- Current neurological or general medical conditions known to impact cognitive and/or emotional functioning (epilepsy, Parkinson's, etc.)
- Acute psychological instability, schizophrenia, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- Baylor College of Medicinecollaborator
Study Sites (1)
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Due to unforeseen circumstances including COVID-19, we were unable to complete the whole project.
Results Point of Contact
- Title
- Ramiro Salas
- Organization
- Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Menninger Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
Ramiro Salas, PhD
Michael E. DeBakey VA Medical Center, Houston, TX
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2018
First Posted
March 29, 2018
Study Start
November 1, 2018
Primary Completion
August 14, 2020
Study Completion
November 24, 2020
Last Updated
June 28, 2024
Results First Posted
June 28, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share